Cat Chronic Kidney Disease Quality of Life: Managing Welfare in CKD Cats

Chronic kidney disease is the leading cause of death in older cats. Managing welfare throughout the long course of CKD requires attention to multiple simultaneously impaired body systems.

Key Facts

CKD affects over 30% of cats over 15 years and is the most common cause of senior cat death
Cats are masters at hiding illness, meaning CKD is typically advanced before clinical signs are obvious
Kidney disease causes nausea, reduced appetite, hypertension, and anaemia affecting multiple welfare dimensions
Dietary management with restricted phosphorus and appropriate protein significantly slows progression
Subcutaneous fluid therapy at home is well-tolerated by most cats and significantly improves quality of life

Welfare Considerations

CKD welfare management requires addressing multiple simultaneous welfare impairments throughout a potentially years-long disease course. Nausea from uraemic toxins reduces appetite and causes discomfort. Hypertension causes retinal damage and neurological changes. Anaemia causes lethargy and exercise intolerance. Appetite stimulants, anti-nausea medication, phosphate binders, anti-hypertensives, and erythropoiesis-stimulating agents each address specific welfare-impairing complications. Subcutaneous fluid administration at home - taught to owners by veterinary nurses - maintains hydration and improves toxin clearance between clinic visits. Quality of life monitoring using validated tools guides treatment decisions including when to transition to palliative care.

What You Can Do

Request regular blood and urine monitoring for cats over 10 years to detect CKD early
Learn subcutaneous fluid administration if your cat is diagnosed with CKD
Discuss all available medical management options with your vet to address all CKD complications
Use validated quality of life tools to guide decisions about treatment escalation and end-of-life care